1. |
Zumla A, Abubakar I, Raviglione M, et al. Drug-resistant tuberculosis-current dilemmas, unanswered questions, challenges, and priority needs. J Infect Dis, 2012, 205(2):228-240.
|
2. |
孟繁荣, 刘志辉, 谢贝, 等.我国利福平敏感结核杆菌rpoB基因利福平耐药定区序列循证分析.实用医学杂志, 2009, 29(21):3601-3604.
|
3. |
Miller LP, Crawford JT, Shinnick TM. The rpoB gene of Mycobacterium tuberculosis. Ntimicrob Agents Ch, 1994, 38(4):805-811.
|
4. |
Palomino J C. Nonconventional and new methods in the diagnosis of tuberculosis:feasibility and applicability in the field. Eur Respir J, 2005, 26(2):339-350.
|
5. |
Palomino JC. Newer diagnostics for tuberculosis and multi-drug resistant tuberculosis. Curr Opin Pulm Med, 2006, 12(3):172-178.
|
6. |
Isfahani BN, Tavakoli A, Salehi M, et al. Detection of rifampin resistance patterns in Mycobacterium tuberculosis strains isolated in Iran by polymerase chain reaction-single-strand conformation polymorphism and direct sequencing methods. Mem Inst Oswaldo Cruz, Rio de Janeiro, 2006, 101(6):597-602.
|
7. |
Scarpellini P, Braglia S, Brambilla AM, et al. Detection of rifampin resistance by single-strand conformation polymorphism analysis of cerebrospinal fluid of patients with tuberculosis of the central nervous system. J Clin Microbiol, 1997, 35(11):2802-2806.
|
8. |
汪保国, 陈思东, 张胜, 等.结核分支杆菌rpoB基因突变与对利福平耐药的关系.实用医学杂志, 2009, 25(7):1022-1024.
|
9. |
Whiting P, Rutjes AW, Reitsma IB, 等. QUADAS的制定:用于系统评价中评价诊断性研究质量的工具(译文).中国循证医学杂志, 2007, 7(4):296-306.
|
10. |
Whiting P, Weswood ME, Rutjes AW, 等. QUADAS评价:一种用于诊断性研究的质量评价工具(修订版)(译文).中国循证医学杂志, 2007, 7(7):531-536.
|
11. |
张天嵩, 钟文昭. Meta Disc软件在诊断试验Meta分析中的应用.循证医学, 2008, 8(2):97-108.
|
12. |
杨柳, 苏明权, 程晓东, 等. PCR-SSCP法检测结核分枝杆菌耐药性.第四军医大学学报, 2004, 24(23):2142-214.
|
13. |
钟敏, 温博海.检测结核分枝杆菌rpoB基因突变的研究.中华检验医学杂志, 2002, 25(1):38-41.
|
14. |
褚美芬, 严杰, 钟雅文, 等.快速检测结核分枝杆菌异烟肼和利福平耐药相关基因mPCR-SSCP建立及应用.中华微生物学和免疫学杂志, 2012, 32(7):655-660.
|
15. |
Cheng X, Zhang J, Yang L, et al. A new Multi-PCR-SSCP assay for simultaneous detection of isoniazid and rifampin resistance in mycobacterium tuberculosis. J Microbiol Meth, 2007, 70:301-305.
|
16. |
Telenti A, Honore N, Bernasconi C, et al. Genotypic assessment of isoniazid and rifampin resistance in mycobacterium tuberculosis: a blind study at reference laboratory level. J Clin Microbiol, 1997, 35(3):719-723.
|
17. |
Sheng J, Li J, Sheng G, et al. Characterization of rpoB mutations associated with rifampin resistance in Mycobacterium tuberculosis from eastern China. J Appl Microbiol, 2008, 105(3):904-911.
|
18. |
Negi SS, Rai A, Gupta S, et al. Characterization of rpoB gene for detection of rifampicin drug resistance by SSCP and sequence analysis. Int J Infect Dis, 2008, 12:e318.
|
19. |
Mani C, Selvakumar N, Kumar V, et al. Comparison of DNA sequencing, PCR-SSCP and PhaB assays with indirect sensitivity testing for detection of rifampicin resistance in mycobacterium tuberculosis. Int J Tuberc Lung D, 2003, 7(7):652-659.
|
20. |
Kim BJ, Lee KH, Yun YJ, et al. Simultaneous identification of rifampin-resistant Mycobacterium tuberculosis and nontuberculous mycobacteria by polymerase chain reaction-single strand conformation polymorphism and sequence analysis of the RNA polymerase gene (rpoB). J Microbiol Meth, 2004, 58(1):111-118.
|
21. |
Wu X, Zhang J, Zhuang Y, et al. Molecular mechanisms of drug resistance in mycobacterium tuberculosis clinical isolates. CMJ, 1999, 112(6):524-528.
|
22. |
Devillé WL, Buntinx F, Bouter LM, et al. Conducting systematic reviews of diagnostic studies:didactic guidelines. BMC Medical Research Methodology, 2002, 2(1):1-13.
|
23. |
柳清云, 孙刚, 高谦.结核分枝杆菌(MTB)异质性耐药研究进展.复旦学报(医学版), 2013, 40(1):1-4.
|
24. |
Bossuyt PMM, Reitsma JB, Bruns DE, et al. The STARD statement for reporting studies of diagnostic accuracy:Explanation and elaboration. Clin Chem, 2003, 49(1):7-18.
|
25. |
Tackmann R'Schuetz G, HammB, et al. Quality of the reporting of diagnostic accuracy studies:STARD (Standards for the Reporting of Diagnostic accuracy studies). Rofo, 2010, 182(8):655-659.
|